Search

Search Constraints

You searched for: Author/Creator Mazzotta, Marco

Search Results

1. A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Issue 2 (1st February 2019)

2. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Issue 4 (3rd April 2018)

3. Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane. Issue 31 (31st July 2020)

4. COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience. Issue 4 (6th March 2021)

5. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019)

6. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Issue 2 (5th August 2020)

7. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Issue 2 (5th August 2020)

8. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Issue 2 (5th August 2020)

9. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Issue 2 (5th August 2020)

10. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Issue 2 (5th August 2020)